NW Biotherapeutics NWBO
COM · Common Stock · CUSIP 66737P600
Development-stage American pharmaceutical company
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 1.1bn as of 2023-08-07, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.57.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 13 |
| Q4 2022 | 15 |
| Q1 2023 | 14 |
| Q2 2023 | 11 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 7 | 0 |
| Q1 2023 | 2 | 2 |
| Q2 2023 | 2 | 3 |
Biggest buyers
| Rothschild Wealth LLC | Added | +279.0k |
| Moloney Securities Asset Management, LLC | Added | +45.5k |
Biggest sellers
| Ancora Advisors LLC | Sold out | -526.0k |
| Ethos Financial Group, LLC | Sold out | -22.2k |
| GRACE & WHITE INC /NY | Sold out | -14.7k |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Rothschild Wealth LLC 0.44% of their portfolio | 2.5m $1.4m | Added +279.0k |
| Moloney Securities Asset Management, LLC 0.03% of their portfolio | 329.7k $187.2k | Added +45.5k |
| Opus Capital Group, LLC 0.01% of their portfolio | 60.1k $34.0k | Unchanged |
| Williams Jones Wealth Management, LLC. 0.00% of their portfolio | 44.0k $25.0k | Unchanged |
| LEE DANNER & BASS INC 0.00% of their portfolio | 20.0k $11.0k | Unchanged |
| MAI Capital Management 0.00% of their portfolio | 20.0k $11.4k | Unchanged |
| AlphaMark Advisors, LLC 0.00% of their portfolio | 14.0k $8.0k | Unchanged |
| ADVISORS MANAGEMENT GROUP INC /ADV 0.00% of their portfolio | 10.3k $6.0k | Unchanged |
| Bartlett & Co. LLC 0.00% of their portfolio | 4.3k $2.0k | Unchanged |
| BARTLETT & CO. WEALTH MANAGEMENT LLC 0.00% of their portfolio | 4.3k $2.4k | Unchanged |
| HANTZ FINANCIAL SERVICES, INC. 0.00% of their portfolio | 250 $0 | Unchanged |